CD34 and lymphoma: Shao Shan et al. [16] reported no significant differences in the quantity of CD34 + cells, MNC counts or time to hematopoietic recovery between PEG-rhG-CSF and rhG-CSF mobilization protocols in patients with relapsed refractory malignant lymphomas.